The Patent Finder

Oxigene, Inc.

Also on record
Records under this name other than patents Oxigene, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Oxigene, Inc.

PatentTitleStatus Expires Confidence
US 8,877,967Compositions and methods for inhibition of cathepsins
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,458,103Compositions and methods for inhibition of cathepsins
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,873,668Compositions and methods for inhibition of cathepsins
Formerly held
Lapsed on the fee record
Ended Jan 23, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 23, 2026From the USPTO record
US 7,456,214Chromene-containing compounds with anti-tubulin and vascular targeting activity
Formerly held
Term ended
Term ended Jan 30, 2025 · From the USPTO record
Term endedTerm ended Jan 30, 2025From the USPTO record
US 7,358,236Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents
Formerly held
Term ended
Term ended Nov 19, 2024 · From the USPTO record
Term endedTerm ended Nov 19, 2024From the USPTO record
US 8,198,302Compositions and methods with enhanced therapeutic activity
Formerly held
Lapsed on the fee record
Ended Jun 12, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 12, 2024From the USPTO record
US 9,040,500Method for treating hematopoietic neoplasms
Formerly held
Lapsed on the fee record
Ended May 26, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 26, 2023From the USPTO record
US 6,773,702Use of Combretastatin A4 and Its Prodrugs as an Immune Enhancing Therapy
Formerly held
Term ended
Term ended Dec 26, 2021 · High confidence
Term endedTerm ended Dec 26, 2021High confidence
US 7,037,906Methods for Modulating Tumor Growth and Metastasis
Formerly held
Term ended
Term ended Dec 20, 2021 · High confidence
Term endedTerm ended Dec 20, 2021High confidence
US 6,593,374Tubulin binding ligands and corresponding prodrug constructs
Formerly held
Term ended
Term ended Jul 27, 2021 · From the USPTO record
Term endedTerm ended Jul 27, 2021From the USPTO record
10 of 30 patents shown.
Pro members see all 30.
Pro members: see all 30 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited